1. Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives
    Lixia Guo et al, 2015, Disease Markers CrossRef
  2. Role of MicroRNA-103a Targeting ADAM10 in Abdominal Aortic Aneurysm
    Tong Jiao et al, 2017, BioMed Research International CrossRef
  3. Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases
    D. Dreymueller et al, 2017, Mediators of Inflammation CrossRef
  4. Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma
    Nuray Erin et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
  5. ADAM10 mediates the cell invasion and metastasis of human esophageal squamous cell carcinoma via regulation of E-cadherin activity
    BO MA et al, 2016 CrossRef
  6. Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer
    Wei Liu et al, 2015, Journal of Ethnopharmacology CrossRef
  7. Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases
    Sabrina Amar et al, 2017 CrossRef
  8. Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease
    Jayda E. Meisel et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  9. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells
    SHAO YUAN et al, 2013 CrossRef
  10. miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer
    Xiancai Ge et al, 2017 CrossRef
  11. Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113
    YUAN SHAO et al, 2015 CrossRef
  12. Overexpression of A disintegrin and metalloprotease 10 promotes tumor proliferation, migration and poor prognosis in hypopharyngeal squamous cell carcinoma
    Chuanjin Ding et al, 2017 CrossRef
  13. Clinical significance of ADAM10 expression in laryngeal carcinoma
    Bo You et al, 2017 CrossRef
  14. ER stress-mediated cell damage contributes to the release of EDA+ fibronectin from hepatocytes in nonalcoholic fatty liver disease
    Lei He et al, 2017, J. Huazhong Univ. Sci. Technol. [Med. Sci.] CrossRef
  15. Cigarette smoke induces the expression of Notch3, not Notch1, protein in lung adenocarcinoma
    ZHENSHUN CHENG et al, 2015 CrossRef
  16. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial–mesenchymal transition through the regulation of ADAM10 and ADAM17
    Ga Bin Park et al, 2018, Mol Cell Biochem CrossRef
  17. Systemic redox status in lung cancer patients is related to altered glucose metabolism
    Katarzyna Zabłocka-Słowińska et al, 2018, PLoS ONE CrossRef
  18. ADAM10 mediates malignant pleural mesothelioma invasiveness
    Christelle Sépult et al, 2019, Oncogene CrossRef
  19. Amyloid precursor protein and its phosphorylated form in non-small cell lung carcinoma
    Shigehiro Ito et al, 2019, Pathology - Research and Practice CrossRef
  20. MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion
    Yi Wan et al, 2013, In Vitro Cell.Dev.Biol.-Animal CrossRef
  21. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells
    Lin Fu et al, 2014, Tumor Biol. CrossRef
  22. Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
    Bo You et al, 2015, Cancer Sci CrossRef
  23. Identification of genes expressed in the migrating primitive myeloid lineage ofXenopus laevis
    Zachary N. Agricola et al, 2016, Dev. Dyn. CrossRef
  24. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma
    Peihang Jing et al, 2016, Experimental and Molecular Pathology CrossRef
  25. Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters
    José Sergio Zepeda-Nuño et al, 2017, Pathol. Oncol. Res. CrossRef
  26. Consistency Test of Ion-Flow Density Measurement System Using an Improved Gray Relational Analysis Method
    Zhaoyang Li et al, 2019, IEEE Trans. Electromagn. Compat. CrossRef
  27. ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p.
    Quan Yuan et al, 2020, Cancer Cell Int CrossRef
  28. Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
    Chen-Chi Liu et al, 2018, Oncotarget CrossRef
  29. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling
    Neha Woods et al, 2015, Oncotarget CrossRef
  30. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers
    Yousef Risha et al, 2020, Sci Rep CrossRef
  31. CircNFIX Acts as a miR-212-3p Sponge to Enhance the Malignant Progression of Non-Small Cell Lung Cancer by Up-Regulating ADAM10


    Jun Lu et al, 2020, CMAR CrossRef
  32. Long noncoding RNA SBF2-AS1 contributes to the growth and metastatic phenotypes of NSCLC via regulating miR-338-3p/ADAM17 axis.
    Qi Chen et al, 2020, Aging (Albany NY) CrossRef
  33. The Effect of Disintegrin–Metalloproteinase ADAM9 in Gastric Cancer Progression
    Jeong Min Kim et al, 2014, Mol Cancer Ther CrossRef
  34. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren V. Owens et al, 2021, Brain Research CrossRef
  35. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation
    Nan Ma et al, 2021, Sci Rep CrossRef
  36. Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway
    Xian-Qiang Ni et al, 2021, Aging CrossRef
  37. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
    Amir Sadra Zangouei et al, 2021, Genes and Environ CrossRef
  38. Aberrant ADAM10 expression correlates with osteosarcoma progression.
    Ren Zhao et al, 2014, Eur. J. Med. Res. CrossRef
  39. Dysregulation of ADAM10 shedding activity in naked mole‐rat fibroblasts is due to deficient phosphatidylserine externalization
    Paulina Urriola‐Muñoz et al, 2023, Journal Cellular Physiology CrossRef
  40. Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study
    Davida Mirra et al, 2023, Biomedicines CrossRef
  41. Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
    Ayelet Sarah Hershkovits et al, 2023, Front. Aging Neurosci. CrossRef
  42. ADAM10 and Neprilysin level decreases in immune cells of mice bearing metastatic breast carcinoma: Possible role in cancer inflammatory response
    Nuray Erin et al, 2024, International Immunopharmacology CrossRef
  43. Investigation of Staphylococcus aureus Biofilm-Associated Toxin as a Potential Squamous Cell Carcinoma Therapeutic
    Zi Xin Ong et al, 2024, Microorganisms CrossRef
  44. IL-12p40 Monomer: A Potential Player in Macrophage Regulation
    Brian Jeong et al, 2024, Immuno CrossRef
  45. Harnessing HEK293 cell-derived exosomes for hsa-miR-365a-3p delivery: Potential application in hepatocellular carcinoma therapy
    Armita Ghotaslou et al, 2024, Heliyon CrossRef
  46. Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma
    Yueh-Feng Lu et al, 2024, Lung Cancer CrossRef